As a part of the GLP-1 receptor agonist class, Retatrutide works by targeting multiple pathways in the body, significantly impacting weight loss, appetite regulation, and blood sugar control.
Retatrutide is a new weight loss treatment that targets multiple hormone pathways related to weight regulation. It belongs to a new class of medications known as GLP-1 receptor agonists, which work by mimicking natural hormones that regulate hunger, satiety, and energy use. By stimulating these receptors, Retatrutide can reduce appetite and increase feelings of fullness after eating, helping you consume fewer calories.
It also influences insulin sensitivity and glucose metabolism, which are essential factors in weight management, especially for those with obesity-related health issues like type 2 diabetes. By addressing these multiple pathways, Retatrutide has shown promising results in helping individuals lose significant amounts of weight.
Retatrutide's mechanism of action involves the stimulation of three crucial hormone receptors that regulate hunger and energy balance:
GLP-1 (Glucagon-like peptide-1): This hormone plays a key role in lowering blood sugar levels and promoting satiety, which helps reduce food intake.
GIP (Glucose-dependent insulinotropic peptide): GIP enhances the secretion of insulin when blood sugar levels rise, further aiding in blood glucose control.
GCG (Glucagon): GCG acts to slow gastric emptying, making people feel full longer and thus contributing to reduced calorie consumption.
By acting on these three receptors simultaneously, Retatrutide offers a more potent approach to weight loss compared to current medications, as it works on multiple pathways to target obesity from various angles.
How Effective is Retatrutide for Weight Loss?
A useful way to put the results from the phase 2 trial into perspective is to compare taking Retatrutide for obesity to taking other weight loss medications. Although the results are not directly comparable (due to differences in the study designs), what we do know suggests Retatrutide may be more effective.
For instance, patients taking the maximum dose of Zepbound (10 mg to 15 mg) lost 20.9% after 36 weeks. This is lower than patients taking the maximum doses of Retatrutide after 48 weeks. In addition, researchers determined that if patients were to continue taking Retatrutide for more than 48 weeks, they would likely lose more weight, as participants had not yet reached a plateau.
It’s possible that Retatrutide will prove to be more effective than other weight loss medications due to its triple action. In particular, activating the GCG receptor enhances the effects of the GIP and GLP-1 agonism. This efficacy suggests the drug could be suitable for patients with greater weight loss needs, including in the case of being an alternative to more invasive treatments like bariatric surgery.
Although Retatrutide may be more effective than weight loss drugs currently on the market, it is not available right now. It’s worth starting treatment as soon as possible and potentially changing to Retatrutide when it becomes available. Connect with a weight loss healthcare provider or doctor near you to receive a prescription.
Other Benefits of Retatrutide
Beyond its efficacy for weight loss, the phase 2 trial found that Retatrutide may provide a number of health benefits, including:
Improvements to blood pressure - both systolic and diastolic
Improved levels of glycated hemoglobin, insulin, and fasting glucose, all of which are indicators of blood sugar. In fact, 72% of participants who had prediabetes at the start of the study had normal glycated hemoglobin levels at 48 weeks, compared to just 22% of patients taking the placebo.
Better blood pressure - 41% of patients in the 8-mg groups and 30% of patients in the 12-mg group were able to stop taking at least one antihypertensive medication after 48 weeks on Retatrutide.
Lower levels of lipids, except high-density lipoprotein (also called good cholesterol), which indicates a lower risk of heart disease and stroke.
In addition to looking at its effectiveness for treating obesity, researchers want to know if Retatrutide could be suitable for managing type 2 diabetes and other conditions, such as non-alcoholic fatty liver disease (NAFLD). These are considerations for the phase 3 trial.
Losing weight is an important way to improve various aspects of your health. Ask Klinic to connect you with a weight loss specialist near you to help you gain the treatment you need.